Induction and Maintenance Therapy With Infliximab for Children With Moderate to Severe Ulcerative Colitis Jeffrey Hyams, Lakshmi Damaraju, Marion Blank,

Slides:

Advertisements

Similar presentations

Irritable Bowel Syndrome and Microscopic Colitis: A Systematic Review and Meta- analysis Eline J.C.A. Kamp, John S. Kane, Alexander C. Ford Clinical Gastroenterology.

Advertisements

Risk of Neoplasia After Colectomy in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis Lauranne A.A.P. Derikx, Loes H.C.

Opened Proton Pump Inhibitor Capsules Reduce Time to Healing Compared With Intact Capsules for Marginal Ulceration Following Roux-en-Y Gastric Bypass

Thrombocytopenia With Abnormal Liver Function Tests

Ashwin N. Ananthakrishnan, Millie D. Long, Christopher F

Saurabh Dawra, Vishal Sharma, Usha Dutta

Certolizumab Pegol in Patients With Moderate to Severe Crohn's Disease and Secondary Failure to Infliximab William J. Sandborn, Maria T. Abreu, Geert.

Effects of Community Screening for Helicobacter pylori: 13-Year Follow-Up Evaluation of a Randomized Controlled Trial Maria Bomme, Jane Møller Hansen,

The Probiotic Preparation, VSL#3 Induces Remission in Patients With Mild-to- Moderately Active Ulcerative Colitis Ajit Sood, Vandana Midha, Govind K.

Laura Rosenberg, Kavinderjit S

Katsunori Matsueda, Tatsuya Toyokawa

A Shocking Cystory Clinical Gastroenterology and Hepatology

Fernando Velayos, Uma Mahadevan

Prevalence of Irritable Bowel Syndrome–type Symptoms in Patients With Celiac Disease: A Meta-analysis Anita Sainsbury, David S. Sanders, Alexander C.

Pushing the Pedal to the Metal: Should We Accelerate Infliximab Therapy for Patients With Severe Ulcerative Colitis? Hans H. Herfarth, MD, PhD Clinical.

Marc E. Schaefer, Jason T. Machan, David Kawatu, Christine R

Endoscopic and Clinical Variables That Predict Sustained Remission in Children With Ulcerative Colitis Treated With Infliximab Dan Turner, Anne M. Griffiths,

The Natural History of Corticosteroid Therapy for Ulcerative Colitis in Children Jeffrey Hyams, James Markowitz, Trudy Lerer, Anne Griffiths, David Mack,

Angel Lanas, Ping Wu, Jennie Medin, Edward J. Mills

Efficacy of Vedolizumab Induction and Maintenance Therapy in Patients With Ulcerative Colitis, Regardless of Prior Exposure to Tumor Necrosis Factor Antagonists

Volume 155, Issue 4, Pages (October 2018)

Metoclopramide Nasal Spray Reduces Symptoms of Gastroparesis in Women, but not Men, With Diabetes: Results of a Phase 2B Randomized Study Henry P. Parkman,

Talya Salz, Robert S. Sandler Clinical Gastroenterology and Hepatology

Personalizing Colorectal Cancer Screening: A Systematic Review of Models to Predict Risk of Colorectal Neoplasia Gene K. Ma, Uri Ladabaum Clinical Gastroenterology.

Proximal Esophageal Varices: A Rare Yet Treatable Cause of Hemorrhage

Activity-Based Costing and Management in a Hospital-Based GI Unit

Michael Hjelkrem, Joel Stengel, Mark Liu, David P. Jones, Stephen A

Francisco A. Sylvester, Scott Leopold, Miriam Lincoln, Jeffrey S

Volume 146, Issue 1, Pages e1 (January 2014)

Joanna Gibson, Jill Lacy, Ellen Matloff, Marie Robert

Safety of Celecoxib in Patients With Ulcerative Colitis in Remission: A Randomized, Placebo-Controlled, Pilot Study William J. Sandborn, William F. Stenson,

Rapid Disappearance of a Pancreatic Cyst After Steroid Therapy in a Patient With Autoimmune Pancreatitis Terumi Kamisawa, Hajime Anjiki, Naoto Egawa

Metastatic Malignant Melanoma of the Gastrointestinal Tract

Low Serum Vitamin D During Remission Increases Risk of Clinical Relapse in Patients With Ulcerative Colitis John Gubatan, Shuji Mitsuhashi, Talia Zenlea,

Human Papillomavirus–Related Rectal Squamous Cell Carcinoma in a Patient With Ulcerative Colitis Diagnosed on Narrow-Band Imaging Ivana Dzeletovic, Shabana.

New Models of Gastroenterology Practice

Dushyant Singh, Reetu Singh, Wendell K. Clarkston

Cannabis Induces a Clinical Response in Patients With Crohn's Disease: A Prospective Placebo-Controlled Study Timna Naftali, Lihi Bar-Lev Schleider,

Prednisolone and Budesonide for Short- and Long-Term Treatment of Microscopic Colitis: Systematic Review and Meta-analysis Michael J. Stewart, Cynthia.

Endoscopic Ultrasound-guided Specimen Collection and Evaluation Techniques Affect Diagnostic Accuracy Ji Young Bang, Udayakumar Navaneethan, Muhammad.

Clinical Gastroenterology and Hepatology

Rebecca M. Lovell, Alexander C. Ford

Corticosteroid Therapy in the Age of Infliximab: Acute and 1-Year Outcomes in Newly Diagnosed Children With Crohn’s Disease James Markowitz, Jeffrey.

Neovaginal Sparing in a Transgender Woman With Ulcerative Colitis

Mucosal Healing Is Associated With Improved Long-term Outcomes of Patients With Ulcerative Colitis: A Systematic Review and Meta-analysis Shailja C.

Effects of Different Coping Strategies on Physical and Mental Health of Patients With Irritable Bowel Syndrome Lilian Dindo, PhD Clinical Gastroenterology.

Issue Highlights Clinical Gastroenterology and Hepatology

Elizabeth Mileti, Philip Rosenthal, Marion G. Peters

An Accelerated Infliximab Induction Regimen Reduces the Need for Early Colectomy in Patients With Acute Severe Ulcerative Colitis David J. Gibson, Zaid.

Association Between Advances in High-Resolution Cross-Section Imaging Technologies and Increase in Prevalence of Pancreatic Cysts From 2005 to 2014 Maria.

Hannah I. Awai, Kimberly P. Newton, Claude B

James Allison, Lisa J. Herrinton, Liyan Liu, Jenny Yu, James Lowder

Probiotics Prevent Hepatic Encephalopathy in Patients With Cirrhosis: A Randomized Controlled Trial Manish Kumar Lunia, Barjesh Chander Sharma, Praveen.

Hepatic Cyst? Clinical Gastroenterology and Hepatology

Thrombocytopenia With Abnormal Liver Function Tests

Volume 132, Issue 3, Pages (March 2007)

A 27-Year-Old Woman With Constipation: Diagnosis and Treatment

Anshu Mahajan, Sean C. Kumer, Andrew Y. Wang

Issue Highlights Clinical Gastroenterology and Hepatology

Issue Highlights Clinical Gastroenterology and Hepatology

Coloduodenal Fistula in Crohn’s Disease

Rintaro Hashimoto, Akimichi Chonan

Adverse Outcomes: Why Bad Things Happen to Good People

Issue Highlights Clinical Gastroenterology and Hepatology

Induction Pegylated Interferon Alfa-2b in Combination With Ribavirin in Patients With Genotypes 1 and 4 Chronic Hepatitis C: A Prospective, Randomized,

Rintaro Hashimoto, Akimichi Chonan

Metastatic Malignant Melanoma of the Gastrointestinal Tract

Self-Administered Cognitive Behavior Therapy for Moderate to Severe Irritable Bowel Syndrome: Clinical Efficacy, Tolerability, Feasibility Jeffrey M.

Combination Therapy With Infliximab and Azathioprine Improves Infliximab Pharmacokinetic Features and Efficacy: A Post Hoc Analysis Jean-Frédéric Colombel,

An Unusual Skin Manifestation in a Patient With Ulcerative Colitis

Presentation transcript:

Induction and Maintenance Therapy With Infliximab for Children With Moderate to Severe Ulcerative Colitis Jeffrey Hyams, Lakshmi Damaraju, Marion Blank, Jewel Johanns, Cynthia Guzzo, Harland S. Winter, Subra Kugathasan, Stanley Cohen, James Markowitz, Johanna C. Escher, Gigi Veereman–Wauters, Wallace Crandall, Robert Baldassano, Anne Griffiths Clinical Gastroenterology and Hepatology Volume 10, Issue 4, Pages 391-399.e1 (April 2012) DOI: 10.1016/j.cgh.2011.11.026 Copyright © 2012 AGA Institute Terms and Conditions

Figure 1 Patient disposition. Clinical Gastroenterology and Hepatology 2012 10, 391-399.e1DOI: (10.1016/j.cgh.2011.11.026) Copyright © 2012 AGA Institute Terms and Conditions

Figure 2 Median partial Mayo scores through week 54 (A). PUCAI clinical remission (B). Median average daily corticosteroid dose through week 54; randomized patients taking corticosteroids at baseline (C). Corticosteroid-free PUCAI clinical remission (D). Clinical Gastroenterology and Hepatology 2012 10, 391-399.e1DOI: (10.1016/j.cgh.2011.11.026) Copyright © 2012 AGA Institute Terms and Conditions

Supplementary Figure 1 CONSORT flow diagram. IVRS, interactive voice response system. Clinical Gastroenterology and Hepatology 2012 10, 391-399.e1DOI: (10.1016/j.cgh.2011.11.026) Copyright © 2012 AGA Institute Terms and Conditions